121 Bio, LLC 121 Bio, LLC, is a Cambridge-based biopharmaceutical start-up company that is developing a unique portfolio of antibody-based solutions for academic and commercial research laboratories. These innovative products will be based on 121 Bio’s core technology platform comprising a proprietary approaches to enzymatic conjugation and single-domain antibody (sdAb) development. 121 Bio’s methodology can […]![]()
